Evidence map›Paper›PMID 41575526›Full record

ArticleVirchows Archiv : an international journal of pathology2026

Mucosa-associated lymphoid tissue lymphoma with monoclonal T-cell expansion.

Kang Jiang, Qun Wang, Yichen Liu, Xiaojun Wang, Wei Rao, Tian Qiu, Xuemin Xue, Xiaoli Feng

Abstract read
PubMed Publisher
In one paragraph

Article in Virchows Archiv : an international journal of pathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Kang Jiang *Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
Qun Wang *Department of Pathology, Binzhou Central Hospital, Binzhou, China.
Yichen Liu *Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
Xiaojun WangDepartment of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
Wei RaoDepartment of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
Tian QiuDepartment of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China. qiutian1228@126.com.
Xuemin XueDepartment of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China. xuexuemin@cicams.ac.cn.
Xiaoli FengDepartment of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China. fengxl@hotmail.com.ORCID http://orcid.org/0000-0001-5663-6006

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prior studies of marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) have mainly emphasized B-cell-intrinsic oncogenic mechanisms and the supportive role of T-cells. However, whether neoplastic B-cells' microenvironment can reciprocally drive T-cell clonality or even promote T-cell neoplastic evolution remains poorly understood. Prompted by an index case where MALT lymphoma evolved into composite lymphoma with peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS), we systematically investigated T-cell receptor (TCR) gene rearrangements in 147 consecutive MALT lymphoma cases diagnosed between 2020 and 2023. TCR clonality was assessed using EuroClonality PCR assays and validated by next-generation sequencing (NGS). Clinicopathologic correlations and histologic spatial patterns of T- and B-cell distribution were evaluated. Monoclonal TCR rearrangement was detected in 16.3% (24/147) of MALT lymphomas. Among them, TCRG rearrangements were significantly enriched in pulmonary cases (25.0%) but were absent in gastric cases (P = 0.0002). Histologically, two distinct patterns of B-T cell distribution were identified. Pattern_1 showed extensive intermingling of B- and T-cells, whereas Pattern_2 displayed relatively segregated growth with limited spatial overlap between the two lineages. Monoclonal TCR rearrangements represent a nonrandom event in a subset of MALT lymphomas, suggesting an underappreciated active role for T-cells in tumor evolution. The preferential enrichment of TCRG rearrangements in pulmonary cases compared with gastric cases highlights site-specific immune milieus shaping T-cell clonality. Together with distinct B-T spatial interaction patterns, these findings support dynamic B-T cell crosstalk and potential multilineage evolution within the MALT lymphoma microenvironment.

Indexed as

MALTMonoclonal rearrangementT-cell lymphomaTCRTET2 mutationTumor microenvironment

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.